Status:
COMPLETED
A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product
Lead Sponsor:
Pfizer
Conditions:
Siderosis
Eligibility:
All Genders
55-90 years
Brief Summary
This protocol intends to detail investigations necessary to evaluate the ocular safety of subjects enrolled in study A4321001 and who have received formulated Drug Product (Lot 8716-098).
Eligibility Criteria
Inclusion
- A subset of subjects enrolled in study A4321001 and who have received formulated drug product (Lot 8716-098) will be included in the safety follow up study.
Exclusion
- None
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00471224
Start Date
June 1 2007
End Date
November 1 2008
Last Update
February 17 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Boston, Massachusetts, United States, 02114
2
Pfizer Investigational Site
Charlotte, North Carolina, United States, 28210
3
Pfizer Investigational Site
Houston, Texas, United States, 77030